Nudging Epidermal Field Cancerogenesis by Imiquimod

Publisher： Karger

E-ISSN： 1421-9832|206|4|357-360

ISSN： 1018-8665

Source： Dermatology, Vol.206, Iss.4, 2003-06, pp. : 357-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Imiquimod Treatment of Lentigo Maligna

By  

Case Reports in Dermatology, Vol. 1, Iss. 1, 2009-10 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Angiolymphoid Hyperplasia with Eosinophilia Successfully Treated with Imiquimod

By  

Dermatology, Vol. 215, Iss. 3, 2007-09 ,pp. : 233-235

Karger

Access to resources Recommend Favorite

5% Topical Imiquimod Tolerance in Transplant Recipients

By  

Dermatology, Vol. 215, Iss. 2, 2007-08 ,pp. : 130-133

Karger

Access to resources Recommend Favorite

Acute Renal Failure Caused by Imiquimod 5% Cream in a Renal Transplant Patient: Review of the Literature on Side Effects of Imiquimod

By  

Dermatology, Vol. 222, Iss. 2, 2011-02 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite